Dr Russell Eugene Rees, MD | |
1 Guthrie Sq, Sayre, PA 18840-1625 | |
(570) 888-5858 | |
(570) 887-2904 |
Full Name | Dr Russell Eugene Rees |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 42 Years |
Location | 1 Guthrie Sq, Sayre, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285607143 | NPI | - | NPPES |
CC9269 | Other | PA | RR MEDICARE GROUP |
1011797650001 | Medicaid | PA | |
CC8362 | Other | NY | RR MEDICARE GROUP |
P00213253 | Other | NY | RR MEDICARE PIN |
P00213253 | Other | PA | RR MEDICARE PIN |
02620097 | Medicaid | NY | |
GU039794 | Other | PA | PA MEDICARE GROUP |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD425473 (Pennsylvania) | Primary |
207V00000X | Obstetrics & Gynecology | 179186-1 (New York) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Robert Packer Hospital | Sayre, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Guthrie Medical Group Pc | 6002728656 | 612 |
Obhg Pennsylvania Pc | 1355684507 | 7 |
News Archive
Volume 11, Issue 22 of @Oncotarget reported that there are rationale and evidence supporting immune therapy in Ovarian Cancers.
Viruses have evolved a broad range of strategies that enable them to evade the immune systems of their hosts. A team of researchers led by LMU virologist Professor J-rgen Haas has been studying a novel, recently discovered mechanism that pathogenic viruses exploit for this purpose, and their latest results could point the way to new antiviral therapies. The mechanism is based on the production of short RNA molecules, called microRNAs, by the virus.
Twenty-six percent of Texans have no health insurance — the highest percentage of medically uninsured residents of any state. It leads the nation in the percentage of children who lack medical insurance. Texas has an inordinate number of employers who provide no insurance to their workers, partly because insurance rates are high, thanks to an absence of regulations.
Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an intermediate lifetime risk of developing the disease.
Access to high-quality, high-value cancer care is crucial for all patients with cancer. Ideally, following a cancer diagnosis, patients should have the option to choose care from an experienced, multi-disciplinary team of sub-specialists at a comprehensive cancer center that offers the latest cancer treatment and supportive care breakthroughs.
› Verified 9 days ago
Entity Name | Guthrie Medical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962451153 PECOS PAC ID: 6002728656 Enrollment ID: O20040301000571 |
News Archive
Volume 11, Issue 22 of @Oncotarget reported that there are rationale and evidence supporting immune therapy in Ovarian Cancers.
Viruses have evolved a broad range of strategies that enable them to evade the immune systems of their hosts. A team of researchers led by LMU virologist Professor J-rgen Haas has been studying a novel, recently discovered mechanism that pathogenic viruses exploit for this purpose, and their latest results could point the way to new antiviral therapies. The mechanism is based on the production of short RNA molecules, called microRNAs, by the virus.
Twenty-six percent of Texans have no health insurance — the highest percentage of medically uninsured residents of any state. It leads the nation in the percentage of children who lack medical insurance. Texas has an inordinate number of employers who provide no insurance to their workers, partly because insurance rates are high, thanks to an absence of regulations.
Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an intermediate lifetime risk of developing the disease.
Access to high-quality, high-value cancer care is crucial for all patients with cancer. Ideally, following a cancer diagnosis, patients should have the option to choose care from an experienced, multi-disciplinary team of sub-specialists at a comprehensive cancer center that offers the latest cancer treatment and supportive care breakthroughs.
› Verified 9 days ago
Entity Name | Obhg Pennsylvania Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184124109 PECOS PAC ID: 1355684507 Enrollment ID: O20190510000946 |
News Archive
Volume 11, Issue 22 of @Oncotarget reported that there are rationale and evidence supporting immune therapy in Ovarian Cancers.
Viruses have evolved a broad range of strategies that enable them to evade the immune systems of their hosts. A team of researchers led by LMU virologist Professor J-rgen Haas has been studying a novel, recently discovered mechanism that pathogenic viruses exploit for this purpose, and their latest results could point the way to new antiviral therapies. The mechanism is based on the production of short RNA molecules, called microRNAs, by the virus.
Twenty-six percent of Texans have no health insurance — the highest percentage of medically uninsured residents of any state. It leads the nation in the percentage of children who lack medical insurance. Texas has an inordinate number of employers who provide no insurance to their workers, partly because insurance rates are high, thanks to an absence of regulations.
Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an intermediate lifetime risk of developing the disease.
Access to high-quality, high-value cancer care is crucial for all patients with cancer. Ideally, following a cancer diagnosis, patients should have the option to choose care from an experienced, multi-disciplinary team of sub-specialists at a comprehensive cancer center that offers the latest cancer treatment and supportive care breakthroughs.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Russell Eugene Rees, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 | Dr Russell Eugene Rees, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 |
News Archive
Volume 11, Issue 22 of @Oncotarget reported that there are rationale and evidence supporting immune therapy in Ovarian Cancers.
Viruses have evolved a broad range of strategies that enable them to evade the immune systems of their hosts. A team of researchers led by LMU virologist Professor J-rgen Haas has been studying a novel, recently discovered mechanism that pathogenic viruses exploit for this purpose, and their latest results could point the way to new antiviral therapies. The mechanism is based on the production of short RNA molecules, called microRNAs, by the virus.
Twenty-six percent of Texans have no health insurance — the highest percentage of medically uninsured residents of any state. It leads the nation in the percentage of children who lack medical insurance. Texas has an inordinate number of employers who provide no insurance to their workers, partly because insurance rates are high, thanks to an absence of regulations.
Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an intermediate lifetime risk of developing the disease.
Access to high-quality, high-value cancer care is crucial for all patients with cancer. Ideally, following a cancer diagnosis, patients should have the option to choose care from an experienced, multi-disciplinary team of sub-specialists at a comprehensive cancer center that offers the latest cancer treatment and supportive care breakthroughs.
› Verified 9 days ago
Dr. Steven Bryan Rouse, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 | |
Barbara L Wiseman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Square, Sayre, PA 18840 Phone: 570-887-3982 Fax: 607-625-5879 | |
Dr. Richard R Lubell, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-2904 | |
Jay K Mehta, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-2530 Fax: 570-887-2904 | |
Dr. Elizabeth Gordon, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Obgyn, Sayre, PA 18840 Phone: 570-888-5858 | |
Samuel Saleeb, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-2530 Fax: 570-887-2904 |